This is particularly important in the real world where we have these same problems in the academic world, but they’re amplified I think in the real world in that getting availability of tissue for sequencing and the time that it takes is problematic. So being able to have an assay that only requires you to draw the patient’s blood speeds this process up considerably...
This is particularly important in the real world where we have these same problems in the academic world, but they’re amplified I think in the real world in that getting availability of tissue for sequencing and the time that it takes is problematic. So being able to have an assay that only requires you to draw the patient’s blood speeds this process up considerably. There is more data presented at this meeting that whether you are MRD positive after your surgery or not is strongly predictive of the benefit of adjuvant chemotherapy. And so, having that answer promptly, not six weeks later, but two weeks later or a week later is actually going to be very important because you need to make decisions about are we going to do chemotherapy or not.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
